The Pharmaceutical Industry
​The Healthcare sector seems to have slightly raised values in last weeks. The MTD performance is +2.54% and one of the most representative society is the biopharmaceutical UCB SA. The Company is specialized in the treatment of central nervous system disorders and inflammatory diseases.
We divide our report in 3 sectors:
- ratio summary
- peer group confrontation
- next 90/180 days share price movement forecasting using our proprietary “Evidence Based Performance Analysisâ€Â© approach
UCB is a global biopharmaceutical company focused on severe diseases in two therapeutic areas, namely central nervous system disorders and immunology. In the area of central nervous system disorders, Co. is focused on advanced Parkinson's disease, epilepsy, restless legs syndrome and epilepsy. In the area of immunology disorders, Co. is focused on rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, systemic lupus erythematosus, juvenile idiopathic arthritis, post-menopausal osteoporosis, systemic lupus erythematosus and immunological diseases.
Since 2003, Ambrosetti Asset Management is a stockbroking company authorized by Governmental Authorities to execute advisory services for investment and wealth management. We are specialized in providing support services to asset management activities (asset selection, asset allocation, market timing, analysis & research) as well as tailor-made solutions and strategies.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.